Patient is actively seizing in the emergency department (ED) for 30 seconds; what orders should I place?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 18, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Immediate Management of Active Seizure in the Emergency Department

Administer intravenous lorazepam 4 mg at 2 mg/min immediately—this is the single most important action for any patient actively seizing, with 65% efficacy in terminating seizures and superior performance compared to diazepam. 1

Critical First Steps (0-5 Minutes)

Immediate Benzodiazepine Administration

  • Give IV lorazepam 4 mg at 2 mg/min as first-line treatment for the actively seizing patient 1
  • Lorazepam demonstrates 59.1% seizure cessation versus 42.6% for diazepam, with longer duration of action 1
  • Have airway equipment (bag-valve-mask, intubation supplies) immediately available before administering any benzodiazepine due to respiratory depression risk 1
  • If IV access is unavailable, administer IM midazolam 10 mg, which has equivalent efficacy to IV lorazepam 1

Simultaneous Rapid Assessment

  • Check fingerstick glucose immediately—hypoglycemia is the most common rapidly reversible cause 1
  • Establish continuous oxygen saturation monitoring with supplemental oxygen available 1
  • Obtain vital signs and prepare for potential respiratory support 1

If Seizure Continues After 30 Seconds to 5 Minutes

Definition and Escalation Threshold

  • Any seizure lasting ≥5 minutes meets the operational definition of status epilepticus and requires immediate escalation to second-line therapy 1
  • Do not wait—early treatment prevents benzodiazepine pharmacoresistance that develops within minutes 2

Second-Line Agent Selection (Choose One)

Valproate is the preferred second-line agent based on superior safety profile:

  • Administer valproate 30 mg/kg IV (maximum 3000 mg) over 5-20 minutes 1, 3
  • Achieves 88% seizure control with 0% hypotension risk 1, 3
  • Absolute contraindication in women of childbearing potential due to teratogenicity 1

Alternative second-line options if valproate is contraindicated:

  • Levetiracetam 30 mg/kg IV (maximum 2500-3000 mg) over 5 minutes 1

    • 68-73% efficacy with minimal cardiovascular effects (0.7% hypotension) 1
    • Excellent choice for elderly patients and those with cardiovascular instability 1
    • No cardiac monitoring required 1
  • Fosphenytoin 20 mg PE/kg IV at maximum rate of 150 PE/min 1

    • 84% efficacy but 12% hypotension risk 1
    • Requires continuous ECG and blood pressure monitoring 1
    • Traditional agent with widest availability 1
  • Phenobarbital 20 mg/kg IV over 10 minutes 1

    • 58.2% efficacy as initial second-line agent 1
    • Higher risk of respiratory depression and hypotension 1
    • Reserve for cases where other agents are unavailable 1

Essential Concurrent Orders

Laboratory Evaluation

  • Serum glucose and sodium—the only labs that consistently change acute ED management 1
  • Pregnancy test in all patients of childbearing potential 1
  • Antiepileptic drug levels if patient has known epilepsy 1

Search for Reversible Causes (Do Not Delay Treatment)

  • Hypoglycemia, hyponatremia, hypoxia 1
  • Drug toxicity or withdrawal (alcohol, benzodiazepines, barbiturates) 1
  • CNS infection, ischemic stroke, intracerebral hemorrhage 1

Neuroimaging Decision

  • Emergent non-contrast head CT if any high-risk features present: 1
    • Age >40 years
    • Recent head trauma
    • Focal seizure onset
    • Fever or persistent headache
    • Anticoagulation use
    • Known malignancy or immunocompromised state
    • Focal neurologic deficit
    • Persistent altered mental status
  • CT abnormalities found in 23-41% of first-time seizure presentations 1
  • Do not delay anticonvulsant administration to obtain neuroimaging 1

Critical Pitfalls to Avoid

  • Never use neuromuscular blockers alone (e.g., rocuronium)—they only mask motor manifestations while allowing continued electrical seizure activity and brain injury 1
  • Do not use phenytoin for drug-induced seizures—there is no role for this agent in toxicologic seizures 4
  • Do not skip to third-line anesthetic agents (pentobarbital, propofol, midazolam infusion) until benzodiazepines and one second-line agent have been tried 1
  • Do not use intramuscular diazepam—absorption is erratic; use rectal route instead if IM administration is being considered 1

Prognosis Context

  • Overall mortality for status epilepticus ranges from 5-22%, increasing to 65% in refractory cases 1
  • Early seizure recurrence occurs in >85% of cases within 360 minutes (mean 121 minutes) 5
  • Patients with alcoholism and history of seizures have highest early recurrence rate at 25.2% 5

References

Guideline

Status Epilepticus Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Treating acute seizures with benzodiazepines: does seizure duration matter?

Epileptic disorders : international epilepsy journal with videotape, 2014

Guideline

Alternative Medications to Diazepam for Seizure Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Treatment of drug-induced seizures.

British journal of clinical pharmacology, 2016

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.